Ixazomib-d7
Ixazomib-d7 is the deuterium labeled Ixazomib (HY-10453). Ixazomib (MLN2238) is a selective, potent, and reversible proteasome inhibitor, which inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with an IC50 of 3.4 nM (Ki of 0.93 nM).
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2177240-89-8
- Fòrmula: C14H12D7BCl2N2O4
- Peso molecular:368.07
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
No. CAS 2177240-89-8
-
Unlabeled Cas 1072833-77-2
-
Peso molecular 368.07
-
Fòrmula C14H12D7BCl2N2O4
-
SMILES
[2H]C([2H])([2H])C(C([2H])([2H])[2H])([2H])C[C@@H](B(O)O)NC(CNC(C1=C(C=CC(Cl)=C1)Cl)=O)=O
-
Synonyms
MLN2238-d7
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)